News

We provide the latest news
from the world of economics and finance

Back
22 January
What Analyst Projections for Key Metrics Reveal About W.R. Berkley (WRB) Q4 Earnings

Wall Street analysts expect W.R. Berkley (WRB) to post quarterly earnings of $0.94 per share in its upcoming report, which indicates a year-over-year decline of 3.1%. Revenues are expected to be $3.51 billion, up 9.1% from the year-ago quarter.

The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.

Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.

While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.

In light of this perspective, let's dive into the average estimates of certain W.R. Berkley metrics that are commonly tracked and forecasted by Wall Street analysts.

It is projected by analysts that the 'Revenues from non-insurance businesses' will reach $167.91 million. The estimate suggests a change of +4.8% year over year.

Analysts' assessment points toward 'Net premiums earned' reaching $2.97 billion. The estimate suggests a change of +9.4% year over year.

The consensus among analysts is that 'Net investment income' will reach $343.66 million. The estimate indicates a year-over-year change of +9.7%.

The combined assessment of analysts suggests that 'Insurance service fees' will likely reach $26.27 million. The estimate indicates a year-over-year change of +4.3%.

Based on the collective assessment of analysts, 'Net premiums earned- Reinsurance & Monoline Excess' should arrive at $351.65 million. The estimate points to a change of +5.9% from the year-ago quarter.

The average prediction of analysts places 'Net premiums earned- Insurance' at $2.61 billion. The estimate indicates a change of +9.5% from the prior-year quarter.

Analysts predict that the 'Expense Ratio - Total' will reach 28.7%. The estimate compares to the year-ago value of 28.4%.

Analysts forecast 'Combined Ratio - Total' to reach 91.3%. Compared to the present estimate, the company reported 88.4% in the same quarter last year.

The consensus estimate for 'Loss Ratio - Insurance Segment' stands at 62.7%. The estimate compares to the year-ago value of 60.8%.

View all Key Company Metrics for W.R. Berkley here>>>

Over the past month, W.R. Berkley shares have recorded returns of +0.8% versus the Zacks S&P 500 composite's +2.1% change. Based on its Zacks Rank #3 (Hold), WRB will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

W.R. Berkley Corporation (WRB) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.